Christian Jung

Christian joined the Dementia Discovery Fund (DDF) as a Partner in 2019. Prior to joining the DDF, Christian worked as a Principal at Wellington Partners, an early and growth-stage life sciences company where he was focused on investing in novel therapeutics and medical devices and served on the Boards of TRiCares and Uromems. Prior to Wellington, Christian was a Senior Investment Manager with High-Tech Gründerfonds where he led the investments in nine seed- and early-stage companies including Amal Therapeutics, Rigontec and Senostic.

Christian holds a PhD in Medical Science and Technology from the Technical University of Munich. He also holds an MSc in Molecular Biotechnology from the Technical University of Munich.